山东大学学报(医学版) ›› 2016, Vol. 54 ›› Issue (9): 53-58.doi: 10.6040/j.issn.1671-7554.0.2016.249
李向一1,孙秀彬1,鹿玉莲2,申振伟1,陈亚飞1,唐芳3,薛付忠1
LI Xiangyi1, SUN Xiubin1, LU Yulian2, SHEN Zhenwei1, CHEN Yafei1, TANG Fang3, XUE Fuzhong1
摘要: 目的 基于队列设计探讨子宫肌瘤与乳腺增生的关联性。 方法 基于常规体检的大样本人群、纵向队列研究,终点事件为乳腺增生,采用Cox比例风险回归模型和Logistic回归模型探讨子宫肌瘤与乳腺增生的关联性。 结果 乳腺增生的发病密度为205.23/千人·年。未调整Cox模型显示子宫肌瘤对乳腺增生的相对危险度RR值为1.26(95%CI:1.12~1.43,P<0.001);调整年龄后,RR值变为1.37(95%CI:1.21~1.55,P<0.001);在上述模型基础上,将是否超重、饮酒、吸烟、睡眠质量等因素纳入多因素Cox模型后,RR值为1.36(95%CI:1.19~1.55,P<0.001)。Logistic回归模型显示,子宫肌瘤对乳腺增生的HR值为1.94(95%CI:1.32~2.85,P<0.001)。 结论 逐层加入危险因素进行调整后,子宫肌瘤与乳腺增生相关,说明子宫肌瘤患者未来发生乳腺增生的风险更大。
中图分类号:
[1] Meisner ALW, Houman Fekrazad M, Royce ME. Breast disease: benign and malignant[J]. Medical Clinics of North America, 2008, 92(5): 1115-1141. [2] Charles RB, Herbert W, Laube DW, et al. Obstetrics and gynecology[M]. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014: 389-392. [3] 张健,施艳秋,任晓梅. 子宫肌瘤与乳腺增生病病因相关性研究进展[J]. 辽宁中医药大学学报, 2011, 13(1): 142-144. ZHANG Jian, SHI Yanqiu, REN Xiaomei. Progress in the study on correlation of etiology between unterine fibroids and mammary gland hyperplasia[J]. Journal of Liaoning University of Traditional Chinese Medicine, 2011, 13(1): 142-144. [4] 梁晓兰,杨永秀. 子宫肌瘤发病的相关危险因素Logistic回归分析[J/CD]. 中国医学前沿杂志, 2015, 7(2): 102-105. LIANG Xiaolan, YANG Yongxiu. Study on the high-risk factors for patients with uterine myoma: a Logistic regression analysis[J/CD]. Chinese Journal of Frontiers of Medical Science, 2015, 7(2): 102-105. [5] 龙安莉. 子宫肌瘤与乳腺增生病的相关性浅析[J]. 吉林医学, 2013, 34(15): 2859-2861. LONG Anli. Analysis of causes of relevance of myoma of uterus and mammary gland hyperplasia[J]. Jilin Medical Journal, 2013, 34(15): 2859-2861. [6] 潘秀群,陈济民. 浅述乳腺增生病与子宫肌瘤的关系[J]. 江西中医药, 2007, 38(3): 15. [7] 张静,张宇,陶鑫焱,等. 社区子宫肌瘤妇女与乳腺疾病的关联性研究[J]. 医学信息, 2014, 27(5): 423. [8] Zhang W, Chen Q, Yuan Z, et al. A routine biomarker-based risk prediction model for metabolic syndrome in urban Han Chinese population[J]. BMC public health, 2015, 15(1): 64. [9] 中华预防医学会妇女保健分会乳腺保健与疾病防治学组. 乳腺增生症的诊治共识(讨论稿)[N]. 中国医学论坛报, 2013-03-18(3). http://guide.medlive.cn/guideline/5532. [10] Greer BE, Koh WJ, Abu-Rustum N, et al. Uterine neoplasms. Clinical practice guidelines in oncology[J]. Journal of the National Comprehensive Cancer Network Jnccn, 2009, 7(5): 498-531. [11] Kabat GC, Jones JG, Olson N, et al. A multi-center prospective cohort study of benign breast disease and risk of subsequent breast cancer[J]. Cancer Causes Control, 2010, 21(6): 821-828. [12] Socolov D, Anghelache I, Ilea C, et al. Benign breast disease and the risk of breast cancer in the next 15 years[J]. Rev Med Chir Soc Med Nat Iasi, 2015, 119(1): 135-140. [13] Cote ML, Ruterbusch JJ, Alosh B, et al. Benign breast disease and the risk of subsequent breast cancer in African American women[J]. Cancer Prevention Research, 2012, 5(12): 1375-1380. [14] Dorjgochoo T, Deming SL, Gao YT, et al. History of benign breast disease and risk of breast cancer among women in China: a case control study[J]. Cancer Causes Control, 2008, 19(8): 819-828. [15] 魏来, 陈长信. 5 000例妇女乳腺疾病筛查及相关因素分析[J]. 中国妇幼保健, 2010, 25(24): 3466-3468. [16] 余雪梅, 王静. 2930例乳腺疾病普查结果分析[J]. 现代医院, 2008,8(6): 144-145. YU Xuemei, WANG Jing. Results analysis for 2930 cases of breast disease[J]. Modern Hospital, 2008, 8(6):144-145. [17] 徐春红. 乳腺增生病的流行病学综述[J]. 北方药学, 2013(12): 92-93. [18] 李玉阳, 杜贾军, 刘奇, 等. 山东省61 102例妇女乳腺疾病普查报告[J]. 山东大学学报(医学版), 2011, 49(8): 157-160. LI Yuyang, DU Jiajun, LIU Qi, et al. Screening for breast diseases among 61,102 women in Shandong Province[J]. Journal of Shandong University(Health Sciences), 2011, 49(8):157-160. [19] Jung MM, Colditz GA, Collins LC, et al. Lifetime physical activity and the incidence of proliferative benign breast disease[J]. Cancer Causes Control, 2011, 22(9): 1297-1305. [20] Boeke CE, Tamimi RM, Berkey CS, et al. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease[J]. Cancer Causes Control, 2015, 26(8): 1-7. [21] Vessey M, Yeates D. Oral contraceptives and benign breast disease: an update of findings in a large cohort study[J]. Contraception, 2007, 76(6): 418-424. [22] Catsburg C, Gunter MJ, Chen C, et al. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease[J]. Cancer Research, 2014, 74(12): 3248-3258. [23] Su X, Boeke CE, Collins LC, et al. Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease[J]. Cancer Causes Control, 2015, 26(1): 79-90. [24] Liu Y, Tamimi RM, Berkey CS, et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease[J]. Pediatrics, 2012, 129(5): 1192-1198. [25] 刘聪,岳永花,郝旭亮. 乳腺增生发病机制的研究进展[J]. 医学综述, 2012, 18(5): 704-706. LIU Cong, YUE Yonghua, HAO Xuliang. Progress of research into the pathogenesis of breast hyperplasia[J]. Medical Recapitulate, 2012, 18(5): 704-706. [26] 李程蕾, 时燕萍. 子宫肌瘤合并乳腺增生病诊治进展[J]. 中医学报, 2010, 25(1): 34-36. LI Chenglei, SHI Yanping. Hysteromyoma merger hyperplasia of mammary glands progress in diagnosis and treatment[J]. China Journal of Chinese Medicine, 2010, 25(1): 34-36. |
[1] | 龚茁,张敏敏,王志萍. 流产经历和子宫肌瘤家族史对子宫肌瘤患病风险的影响[J]. 山东大学学报(医学版), 2017, 55(9): 100-104. |
[2] | 曹瑾,季晓康,孙秀彬,蒋正,薛付忠. γ-谷氨酰转肽酶与高尿酸血症关系的队列分析[J]. 山东大学学报(医学版), 2017, 55(6): 124-128. |
[3] | 柳晓涓,蒋正,康凤玲,周苗,林伟强,薛付忠. 中性粒细胞计数与非酒精性脂肪肝关联性的前瞻性队列研究[J]. 山东大学学报(医学版), 2017, 55(6): 119-123. |
[4] | 申振伟,季晓康,王庆莲,李洁,薛付忠,刘静. 非酒精性脂肪肝与慢性肾脏病关系的回顾性队列研究[J]. 山东大学学报(医学版), 2016, 54(7): 43-49. |
[5] | 刘冉,陶国伟,甄军晖,罗霞,千日成. ER、PR在妊娠期子宫肌瘤组织中的表达及意义[J]. 山东大学学报(医学版), 2016, 54(5): 45-49. |
[6] | 李玉阳1,2,杜贾军2,刘奇2,余之刚1. 山东省61102例妇女乳腺疾病普查报告[J]. 山东大学学报(医学版), 2011, 49(8): 157-160. |
|